Predictive Biomarkers and Therapeutic Response in Early Disease

The chapter delves into the challenges with using histology as a predictive tool in fibroblasts and stromal cells, advocating for the exploration of differentially expressed genes and synovial biopsy in early-stage disease instead. The speakers underscore the significance of clinically relevant biomarkers and the transition towards more accessible ones to enhance targeted therapy efficacy and patient well-being.